Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.35 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.35 |
| ▸ | CHRM2 known ✓ | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 known ✓ | P08173 | 1/20 | 0.34 |
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | SLC5A7 | Q9GZV3 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PDE4A | P27815 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL5257688 | 0.98 | MEN1 (0.55) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL29697295 | 0.98 | MEN1 (0.55) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL2223494 | 0.98 | MEN1 (0.55) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL4258138 | 0.95 | MEN1 (0.52) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL9581035 | 0.95 | MEN1 (0.52) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL27453848 | 0.95 | MEN1 (0.52) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL9296176 | 0.92 | CYP3A4 (0.50) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL188002 | 0.90 | LMNA (0.46) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL2586847 | 0.90 | LMNA (0.46) | CYP3A4SLC5A7LMNAMEN1KMT2A | |
| Cadaverine Tartrate SCHEMBL8167949 | 0.90 | LMNA (0.46) | CYP3A4SLC5A7LMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111087299-B | Method for extracting vanillic acid by using eutectic solvent/n-propanol aqueous two-phase system | 华南理工大学 | 2021-09-21 | — | — | CN | claimed |
| CN-111087299-A | Method for extracting vanillic acid by using eutectic solvent/n-propanol aqueous two-phase system | 华南理工大学 | 2020-05-01 | — | — | CN | claimed |
| CN-110629253-A | Method for electrorefining lead bullion by using ionic liquid and method for recovering metal bismuth and silver | 昆明理工大学 | 2019-12-31 | — | — | CN | claimed |
| CN-106928055-A | A kind of method that use choline eutectic solvent catalyzes and synthesizes aspirin | 南阳理工学院 | 2017-07-07 | — | — | CN | claimed |
| WO-2023170451-A1 | PROCESS OF SOLUBILIZATION OF THE SMOKE CONSTITUENTS IN THE VASE OF THE WATER PIPE USING DEEP EUTECTIC SOLVENTS | GERGES ADNAN FAYAD (LB) | 2023-09-14 | — | — | WO | disclosed |
| CN-113061727-B | Method for selectively leaching metal components in waste lithium cobalt oxide battery by polyethylene glycol-citric acid solvent | 浙江大学衢州研究院 | 2023-05-02 | — | — | CN | disclosed |
| US-11311593-B2 | Root extracts from plants of the Morus genus and uses of same | PLANT ADVANCED TECHNOLOGIES PAT (FR) | 2022-04-26 | — | — | US | disclosed |
| CN-111087299-B | Method for extracting vanillic acid by using eutectic solvent/n-propanol aqueous two-phase system | 华南理工大学 | 2021-09-21 | — | — | CN | disclosed |
| US-11123718-B2 | Oxovanadium phosphate catalyst, and preparation method and application therefor | INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES (CN) | 2021-09-21 | — | — | US | disclosed |
| CN-110629253-B | Method for electrorefining lead bullion by using ionic liquid and method for recovering metal bismuth and silver | 昆明理工大学 | 2021-07-02 | — | — | CN | disclosed |
| CN-113061727-A | Method for selectively leaching metal components in waste lithium cobaltate batteries by using polyethylene glycol-citric acid solvent | 浙江大学衢州研究院 | 2021-07-02 | — | — | CN | disclosed |
| CN-108325545-B | Vanadyl phosphate catalyst, preparation method and application thereof | 中国科学院过程工程研究所 | 2021-01-26 | — | — | CN | disclosed |
| CN-106928055-B | A method of aspirin is catalyzed and synthesized using choline eutectic solvent | 南阳理工学院 | 2019-11-29 | — | — | CN | disclosed |
| CN-110218232-A | The extracting method of polygonin in a kind of polygonum cuspidate | 武夷学院 | 2019-09-10 | — | — | CN | disclosed |
| WO-2019153387-A1 | OXOVANADIUM PHOSPHATE CATALYST, AND PREPARATION METHOD AND APPLICATION THEREFOR | 中国科学院过程工程研究所 | 2019-08-15 | — | — | WO | disclosed |
| CN-109627148-A | A kind of preparation method of cannabidiol, cannabidiol obtained and application thereof | 中国农业科学院麻类研究所 | 2019-04-16 | — | — | CN | disclosed |
| CN-108623709-A | A kind of extracting method of chitin | 中国海洋大学 | 2018-10-09 | — | — | CN | disclosed |
| CN-108325545-A | A kind of vanadyl phosphate catalyst, preparation method and the usage | 中国科学院过程工程研究所 | 2018-07-27 | — | — | CN | disclosed |
| CN-107602720-A | A kind of method of eutectic solvent/salt Bi-aqueous extraction cynomorium songaricum polysaccharide | 西北师范大学 | 2018-01-19 | — | — | CN | disclosed |
| CN-106928055-A | A kind of method that use choline eutectic solvent catalyzes and synthesizes aspirin | 南阳理工学院 | 2017-07-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11311593-B2 | Root extracts from plants of the Morus genus and uses of same | HNRNPF, HNRNPU, PNN | CHRM1 3522/4885CHRM3 4216/4885CHRM2 3150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.